ASHTON ANINZO: Open Payments
NPI 1639746431 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 13 payments from 8 companies in 2025. Trend: 2023 $138 · 2024 $177 · 2025 $639
Food & beverage: $379Education: $245Travel & lodging: $14
| Company | Payments | Amount |
|---|---|---|
| PTC Therapeutics, Inc. | 2 | $263 |
| Zevra Therapeutics Inc | 1 | $132 |
| Cycle Pharmaceuticals Inc | 2 | $53 |
| GENZYME CORPORATION | 2 | $44 |
| Eton Pharmaceuticals, Inc. | 1 | $43 |
| Amicus Therapeutics, Inc. | 2 | $41 |
| Ultragenyx Pharmaceutical Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: SEPHIENCE, Olpruva, Javygtor, GALZIN, Dojolvi, VPRIV.
Industry payments across TX — which companies pay providers there.
